SCHEMBL8795265

SCHEMBL8795265

NCCCc1ccc(NS(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 5/20 0.82
HDAC1 Q13547 4/20 0.64
HDAC8 Q9BY41 3/20 0.64
HDAC4 P56524 1/20 0.59
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
ALDH1A1 P00352 1/20 0.59
PKM P14618 1/20 0.59
KEAP1 Q14145 2/20 0.58
IL1RN P18510 1/20 0.58
ERAP1 Q9NZ08 1/20 0.58
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
CA9 Q16790 1/20 0.57
GHSR Q92847 1/20 0.55
FFAR1 O14842 1/20 0.54
FFAR4 Q5NUL3 1/20 0.54
LIMK2 P53671 1/20 0.53
AR P10275 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5830405 0.90 HTR6 (1.00) HTR6HDAC1HDAC8HDAC4MEN1
SCHEMBL28219031 0.84 FFAR1 (0.74) HTR6HDAC1HDAC8HDAC4MEN1
SCHEMBL3125892 0.84 HTR6 (1.00) HTR6MEN1KMT2AALDH1A1PKM
SCHEMBL7612902 0.83 HTR6 (0.76) HTR6HDAC1HDAC8HDAC4MEN1
SCHEMBL8867847 0.82 HTR6 (0.73) HTR6HDAC1HDAC8HDAC4MEN1
SCHEMBL11027242 0.82 FFAR1 (0.66) HTR6HDAC1HDAC8HDAC4MEN1
SCHEMBL2692935 0.82 HDAC1 (0.78) HTR6HDAC1HDAC8HDAC4MEN1
SCHEMBL8867856 0.81 HTR6 (0.71) HTR6HDAC1HDAC8HDAC4MEN1
SCHEMBL20245194 0.81 HTR6 (0.71) HTR6HDAC1HDAC8HDAC4MEN1
SCHEMBL2691131 0.81 HDAC1 (0.78) HTR6HDAC1HDAC8HDAC4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5652239-A TREATMENT OF STROKES, ISCHEMIC ATTACK, ANTAGONISTS OF EXCITATORY AMINO ACIDS GLUTAMATE AND ASPARTATE IMPERIAL CHEMICAL COMPANY (GB) 1997-07-29 US disclosed
EP-0611003-B1 Substituted phenyl sulfonamides as selective B3 agonists for the treatment of diabetes and obesity MERCK & CO INC (US) 1997-06-18 EP disclosed
EP-0512817-B1 Pyridazinedione derivatives, their preparation and pharmaceutical applications ZENECA LTD (GB) 1997-02-19 EP disclosed
US-5451677-A Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity MERCK & CO., INC. (US) 1995-09-19 US disclosed
EP-0611003-A1 Substituted phenyl sulfonamides as selective B3 agonists for the treatment of diabetes and obesity MERCK & CO. INC. (US) 1994-08-17 EP disclosed
EP-0512817-A1 Pyridazinedione derivatives, their preparation and pharmaceutical applications ZENECA LIMITED (GB) 1992-11-11 EP disclosed